QQ客服 官方微博 反馈留言

	Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease
	Shen, Yan; Zheng, Song-bai; Zou, Jun; Guan, Jian-long; Ji, Da-Nian
刊名	ANNALS OF CLINICAL AND LABORATORY SCIENCE
	2017
卷号	47期号:2
关键词	intestinal Behcet's disease (BD) infliximab (IFX) corticosteroid-free remission mucosal healing (MH) Disease active index of BD (DAIBD)
ISSN号	0091-7370
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3623034
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Shen, Yan,Zheng, Song-bai,Zou, Jun,et al. Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease[J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE,2017,47(2).
APA	Shen, Yan,Zheng, Song-bai,Zou, Jun,Guan, Jian-long,&Ji, Da-Nian.(2017).Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease.ANNALS OF CLINICAL AND LABORATORY SCIENCE,47(2).
MLA	Shen, Yan,et al."Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease".ANNALS OF CLINICAL AND LABORATORY SCIENCE 47.2(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。